Member Info for GF123

ONW. Whilst I agree the timing of the OO could suggest that a deal isn�t done there is another way of looking at it. In that maybe the deal wasn�t quite done then and rather than negotiate with a weaker position at that time a 20% dilution gave instant cash to take IP forward (if needed) and together with the potential �20m from CRUK, to help take IP forward, was it indeed a necessary evil? Indeed they have cash for SCIB 1 trial yet no announcement on when it starts. Just as confusing don�t you agree as the timing of the OO? Also take a look at the most recent SCLP tweet. You could read it as saying to a potential partner/suitor look we are about to get $25m from CRUK. (Could suggest US player?) Are you sure you want us to take our IP forward alone when you can deal now? If we do let us do it alone it could cost you a lot more later on. Anyway you and I have very different view on sclp. Personally I think it�s only a matter of time so holding and buying more seems the best logical return here for me. I guess you won�t agree but there is a reason I�m holding the volume I do. I don�t think it�s about what your investment strategy is here. It�s how confident are you that value will be realised and of course when. On both counts I think quite a bit of value and maybe not too long to wait now. I�d rather hold 1m of shares I�ve purchased than 10k of freebies if it goes boom. Can anyone really say they are 100% correct when we don�t sit on sclp board? ATB

ONW. Without being too confrontational to you have you considered that any deal on Modi could be �conditional� on patent grant. Not �conditional� on intent to grant. The EPO are being very clear. Grant of Modi patent is 13th June. It�s not up to Sclp to be any clearer nor the EPO, because they both have, it�s up to the market to get what could happen. So in simple terms I don�t agree with your statement here. I�ve done plenty of conditional contracts and they kick in when terms of the conditions are satisfied and not until. BTW. im NOT stating a �conditional� deal is done. I�m just stating I disagree that any news on patent grant on the 13th wont affect the SP because it�s not new News. Indeed it could very well be a significant trigger. Let�s see. ATB

don't forget modi patent grant on the 13th June. ATB

https://mobile.twitter.com/scancellpharma?lang=en $25m. Indeed what does that provide for in terms of taking IP forward. Could sclp be negotiating in US right now? Going to be an interesting few months IMO. ATB.

Global Melanocyte Protein PMEL Market Professional Survey Report 2018 https://www.researchmoz.us/global-melanocyte-protein-pmel-market-professional-survey-report-2018-report.html

The rns will be on grant of patent. Not the decision to grant. Rns will be after or on 13th June imo. ATB

Great news. Question is does AIM already have this priced in, which I would say certainly not, and is this a catalyst to more news. Let�s see. ATB.

https://www.scancell.co.uk/file-manager/publications/novel-tumour-antigens-brentville-et-al-2018.pdf

Happy birthday C7. You have a final to look forward too as well! ATB

Not guilty. ATB

Pretty much. Or just out of ideas? A bit touchy too I suggest. ATB

You have to give it to them. They keep trying. ATB

Just read in this weeks "Highways" that Carillion-Mouchel JV have submitted final bids for £1.2 billion road maintenance contract. They are up against only Amey and winner will be anounced end of April with work starting in August. I think there is positive accounting news next week so Im going to get in now with fingers crossed that its heading back to 18p. Looking good!